Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613)
Hong Kong
· Delayed Price · Currency is HKD 7.36
-0.14 (-1.87%)
Sep 9, 2024, 11:35 AM HKT
Beijing Tong Ren Tang Chinese Medicine Company Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 494.14 | 540.39 | 645.88 | 607.84 | 542.46 | 556.12 | Upgrade
|
| Depreciation & Amortization | 82.13 | 80.45 | 73.6 | 69.02 | 78.09 | 79.24 | Upgrade
|
| Other Amortization | 3.1 | 2.06 | 1.87 | 0.96 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.38 | 0.38 | -0.03 | 0.44 | 2.12 | 2.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.05 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.88 | -2.88 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 3.26 | 3.26 | 1.54 | -0.26 | 0.86 | 1.97 | Upgrade
|
| Provision & Write-off of Bad Debts | 21.19 | 21.19 | 6.48 | 7.52 | 3.33 | 3.4 | Upgrade
|
| Other Operating Activities | -924.55 | -149.7 | 144.97 | 31.62 | -88.85 | 94.08 | Upgrade
|
| Change in Accounts Receivable | 492.15 | 492.15 | -434.16 | 23.19 | -219.54 | -133.9 | Upgrade
|
| Change in Inventory | -543.6 | -543.6 | -47 | 64.96 | -168.75 | -82.29 | Upgrade
|
| Change in Accounts Payable | 17.12 | 17.12 | 154.24 | -28.1 | -33.66 | 30.32 | Upgrade
|
| Operating Cash Flow | -357.57 | 460.83 | 547.44 | 777.17 | 116.05 | 551.01 | Upgrade
|
| Operating Cash Flow Growth | - | -15.82% | -29.56% | 569.66% | -78.94% | -4.62% | Upgrade
|
| Capital Expenditures | -26.06 | -21.87 | -38.51 | -23.43 | -12.88 | -16.99 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.06 | 0.13 | 0.02 | 0.03 | 0.11 | Upgrade
|
| Cash Acquisitions | - | - | -3.26 | -13.55 | - | - | Upgrade
|
| Investment in Securities | 573.08 | -1,126 | 362.27 | -234 | 490.56 | 803.95 | Upgrade
|
| Other Investing Activities | 75.9 | 69.17 | 14.79 | 5.22 | 29.02 | 48.47 | Upgrade
|
| Investing Cash Flow | 622.95 | -1,079 | 335.41 | -265.73 | 506.73 | 835.54 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.39 | 1.39 | - | Upgrade
|
| Long-Term Debt Repaid | - | -58.73 | -56.48 | -50.66 | -46.78 | -45.94 | Upgrade
|
| Net Debt Issued (Repaid) | -60.67 | -58.73 | -56.48 | -50.28 | -45.39 | -45.94 | Upgrade
|
| Common Dividends Paid | -276.24 | -276.24 | -234.39 | -200.9 | -192.54 | -192.53 | Upgrade
|
| Other Financing Activities | -32.5 | -37.21 | -35.28 | -27.47 | -26.37 | -37.49 | Upgrade
|
| Financing Cash Flow | -369.41 | -372.18 | -535.42 | -278.65 | -264.3 | -878.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.29 | -1.28 | -16.78 | 1.48 | 10.85 | -1 | Upgrade
|
| Net Cash Flow | -105.32 | -991.15 | 330.66 | 234.26 | 369.33 | 506.88 | Upgrade
|
| Free Cash Flow | -383.63 | 438.97 | 508.94 | 753.74 | 103.17 | 534.02 | Upgrade
|
| Free Cash Flow Growth | - | -13.75% | -32.48% | 630.55% | -80.68% | 1.82% | Upgrade
|
| Free Cash Flow Margin | -27.87% | 28.79% | 29.40% | 48.44% | 7.84% | 37.28% | Upgrade
|
| Free Cash Flow Per Share | -0.46 | 0.52 | 0.61 | 0.90 | 0.12 | 0.64 | Upgrade
|
| Cash Interest Paid | 6.53 | 5.98 | 4.66 | 4.71 | 4.3 | 4.21 | Upgrade
|
| Cash Income Tax Paid | 231.04 | 231.04 | 19.16 | 137.84 | 211.54 | 6.15 | Upgrade
|
| Levered Free Cash Flow | -513.51 | 317.64 | 315.94 | 593.34 | -36.95 | 396.13 | Upgrade
|
| Unlevered Free Cash Flow | -509.43 | 321.37 | 318.85 | 596.28 | -34.26 | 398.76 | Upgrade
|
| Change in Net Working Capital | 913.06 | 128.21 | 220.92 | -67.15 | 501.76 | 70.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.